James R. Berenson
0000-0003-1587-6104
Publication & Citation Trends
Publications
555 total
Balloon kyphoplasty versus non-surgical fracture management for treatment of painful vertebral body compression fractures in patients with cancer: a multicentre, randomised controlled trial
Cited by 518
OpenAlex
Frequency, Characteristics, and Reversibility of Peripheral Neuropathy During Treatment of Advanced Multiple Myeloma With Bortezomib PDF
Cited by 646
OpenAlex
A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma PDF
Cited by 740
OpenAlex
The proteasome inhibitor PS-341 markedly enhances sensitivity of multiple myeloma tumor cells to chemotherapeutic agents.
Cited by 418
OpenAlex
American Society of Clinical Oncology Clinical Practice Guidelines: The Role of Bisphosphonates in Multiple Myeloma
Cited by 541
OpenAlex
Pharmacokinetics and Pharmacodynamics of Zoledronic Acid in Cancer Patients with Bone Metastases
Cited by 371
OpenAlex
Assessment of thymic output in adults after haematopoietic stemcell transplantation and prediction of T-cell reconstitution
Cited by 576
OpenAlex
Research Topics
Multiple Myeloma Research and Treatments
(368)
Protein Degradation and Inhibitors
(120)
Peptidase Inhibition and Analysis
(81)
Bone health and treatments
(79)
Ubiquitin and proteasome pathways
(51)
Affiliations
Rutgers, The State University of New Jersey
Northwestern University
University of North Carolina at Chapel Hill
Scripps Research Institute
Cedars-Sinai Medical Center